S-1: SolarWindow Technologies Files for Resale of Up to 1.18 Million Shares

SolarWindow Technologies is registering for the resale of up to 1,180,000 shares of its common stock by existing stockholders, primarily officers and directors, underlying vested stock purchase options.

Summary

• SolarWindow Technologies has filed a registration statement for the resale of up to 1,180,000 shares of its common stock.
• The shares are issuable upon the exercise of outstanding and vested stock purchase options.
• The exercise prices for these options range from $0.33 to $6.21 per share.
• Selling stockholders include employees, consultants, officers, and directors of the company.
• The company will not receive any proceeds from the sale of these shares by the selling stockholders, but may receive proceeds from the cash exercise of the stock purchase options.
• As of October 17, 2024, the closing price of SolarWindow's common stock was $0.46 per share on the OTC PINK.
• The selling stockholders may sell their shares in the open market, in privately negotiated transactions, or through a combination of methods.
• As of the date of the prospectus, there were 53,198,399 shares of common stock issued and outstanding.
• If all resale shares are sold, there will be 54,383,399 shares issued and outstanding after the exercise of the stock purchase options.

Sentiment

Score: 4

Explanation: The document is largely factual, but the inclusion of numerous risk factors and the company's history of losses contribute to a slightly negative sentiment.

Positives

• The company may receive proceeds from the cash exercise of the stock purchase options.
• Registration allows existing stockholders to liquidate their holdings.

Negatives

• The company will not receive any proceeds from the sale of shares by the selling stockholders.
• The resale of a large number of shares could put downward pressure on the stock price.
• The offering involves a high degree of risk, as noted in the Risk Factors section of the prospectus.

Risks

• The purchase of the Resale Shares offered through this prospectus involves a high degree of risk.
• The company has not generated any revenues and has experienced significant losses to date, and we expect to continue incur losses for the foreseeable future.
• The company will require additional financing in the future to maintain and expand operations into advanced stages of product development and fabrication, and failure to obtain such financing would have a material adverse effect on our business, operating results, financial condition and prospects.
• The development of the company's technology is subject to the risks of failure inherent in the development of any novel technology.
• The company is operating in a highly fragmented and competitive market and our competitors have several competitive advantages over us.
• Technological changes could render the company's products uncompetitive or obsolete, which could prevent us from achieving market share and sales.
• If the company's products do not gain market acceptance, we may not achieve sales and market share.
• The company's business model and strategy are based on growth through licensing, joint ventures, collaborative research and development agreements and acquisitions, that may be difficult to execute, and it may disrupt our business, create integration issues, impair our results of operations, dilute our stockholders ownership, cause us to incur debt, divert management resources, or cause us to incur significant expense.
• The company may be the subject of product liability claims and other adverse effects due to defective products, design faults or harm caused to persons and property.
• The company lacks sales, marketing and manufacturing experience and will likely rely on third party marketers.
• The company may not be able to integrate our process and/or technologies into a manufacturing process necessary to produce a manufacturable product.
• The company could be exposed to liability if we experience security breaches or other disruptions, which could harm our reputation and business.
• Litigation and other legal proceedings may adversely affect our business, financial condition, and results of operations.
• The company's articles of incorporation provide for indemnification of officers and directors at our expense and limit their liability, which may result in a major cost to us and hurt the interests of our stockholders because corporate resources may be expended for the benefit of officers and/or directors and may inhibit actions against our officers and directors.
• The company's insurance coverage may not be adequate to protect us from all business risks.
• The company's business is and may become subject to complex and evolving U.S. and foreign laws and regulations regarding privacy, data use and data protection, content, competition, safety and consumer protection, e-commerce, and other matters.
• There may be limitations on the effectiveness of the company's internal controls, and the failure of our control systems to prevent error or fraud may materially harm our Company.
• The company's products or the application thereof will be subject to environmental, occupational safety & health regulations, as well as regulations dealing with, among other matters, harmful or hazardous materials.
• The company is subject additional compliance expense as well potential liability for any alleged violations of the securities laws and regulations to which we are or may be subject (the Securities Laws & Regulations).
• The company may expand our operations abroad where we have limited operating experience and may be subject to increased business and economic risks that could affect our financial results.
• The company's ability to operate profitably is directly related to our ability to develop, protect, and perfect rights in and to our proprietary technology.
• The company may not be able to adequately protect our intellectual property right from infringement by unauthorized persons or competitors.
• The company may be accused of infringing the intellectual property rights of others.
• The company may be unable to adequately prevent disclosure of trade secrets and other proprietary information, or the misappropriation of the intellectual property we regard as our own.
• The company is dependent upon hiring and retaining highly qualified management and technical personnel.
• Due to the fact each of our three directors conducts outside business activities and are not our employees, attention and efforts will not be focused solely on our business activities, which may hinder our achieving our business objectives.
• Due to our small size each of our officers and consultants has a significant influence on our operations and access to sensitive information, which, if an officer or consultant goes rogue, could result in significant damage to, without limitation, the Companys operations, reputation, financial health, and security of our intellectual property.
• The company is not a fully reporting company under the Securities Exchange Act of 1934, as amended, which we refer to as the Exchange Act; therefore, we are subject only to the reporting requirements of Section 15(d) of the Exchange Act.
• The company's common stock is currently quoted on the OTC PINK (Current Information) which may make it more difficult for you to purchase or sell shares of the Companys Common Stock.
• Financial Industry Regulatory Authority (FINRA) sales practice requirements may also limit a stockholders ability to buy and sell our common stock, which could depress the price of our common stock.
• There is a limited market for our common stock, which may make it difficult for holders of our common stock to sell their stock.
• The trading price of our common stock has been and will likely continue to be volatile.
• If securities or industry analysts do not publish, or cease publishing, research or publish inaccurate or unfavorable research about our business or our market, or if they change their recommendations regarding our stock adversely, our stock price and any trading volume could decline.
• The sale or availability for sale of substantial amounts of our common stock could adversely affect their market price.
• Adverse publicity about us and/or our brands, including without limitation, through social media or in connection with brand damaging events and/or public perception, could negatively impact our business.
• As a smaller reporting company within the meaning of the Securities Act, we may utilize certain modified disclosure requirements, and we cannot be certain if these reduced requirements will make our common stock less attractive to investors.
• The sale by our stockholders of restricted shares, either pursuant to a resale prospectus or Rule 144, may adversely affect our ability to raise the funds we will require to effectuate our business plan.
• Kalen Capital Corporation (KCC), a private corporation solely owned by Mr. Harmel S. Rayat, beneficially owns approximately 72.68% of our issued and outstanding stock when giving effect to derivative securities owned by KCC. This ownership interest may preclude you from influencing significant corporate decisions.
• The company is a controlled company and as a result our stockholders do not have the same protections afforded to stockholders of companies that are not controlled companies.
• The company may be subject to compliance with rules requiring the adoption of certain corporate governance measures, which require control measures for related party transactions, conflicts of interest and similar matters.
• There are options to purchase shares of our common stock currently outstanding.
• There are warrants to purchase shares of our common stock currently outstanding.
• The company may issue preferred stock which may have greater rights than our common stock.
• The Company may sell additional equity securities in the future and your ownership interest in the Company may be diluted because of such sales.
• O ur compliance with changing laws and rules regarding corporate governance and public disclosure may result in additional expenses to us which, in turn, may adversely affect our ability to continue our operations.
• Because we do not intend to pay dividends for the foreseeable future, you should not purchase our shares if you are seeking dividend income.

Future Outlook

The company anticipates remaining engaged in technology and product development for the foreseeable future and expects to raise additional funds through private or public equity investment in order to expand the range and scope of its business operations.

Industry Context

The company operates in the alternative and renewable energy industry, which is characterized by intense competition, rapid product development, and technological change.

Related Party Transactions

• Joseph Sierchio, a director, provides legal services to the company through Sierchio Law LLP.

Stakeholder Impact

• Existing shareholders may experience dilution if the stock purchase options are exercised.
• The resale of shares by existing stockholders could put downward pressure on the stock price.
• The company's future success depends on its ability to develop and commercialize its technology.

Next Steps

• Selling stockholders may offer and sell shares from time to time.
• The company will continue its research and development efforts.
• The company will seek additional financing as needed.

Key Dates

Keywords

resale, common stock, stock options, selling stockholders, SolarWindow Technologies, WNDW, OTC PINK, registration statement, securities